LENZ Therapeutics(LENZ)
SOLANA BEACH, CABiotechnology
Focus: LENZ Therapeutics is a public biotech company focused on ophthalmology treatments, with a recently launched product (VIZZ/Aceclidine) and a pipeline concentrated on presbyopia indications.
Profile data last refreshed 2h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
0
About LENZ Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow LENZ Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from LENZ Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
6/9 — Partial
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$0K
Key Products
Growing
Growth17.5yr
First marketed product, recently launched; aceclidine is a novel parasympathomimetic agent targeting accommodative amplitude in aging eyes.
Help build intelligence for LENZ Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.